SREBF1 and cancer: Increased expression of FASN, SCD1 and SREBP-1c is associated with multiple forms of cancer, and lipogenesis inhibitors that block the activities of FASN9, SCD1 and SREBP-1c have been shown to reduce cancer cell proliferation and induce apoptosis10.